These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18763674)

  • 21. Adverse drug reaction reporting--1998.
    Sutcliffe H
    CMAJ; 1999 Apr; 160(7):1051, 1055. PubMed ID: 10207351
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adverse psychological drug effects. Methodological problems in detection and examples from clinical practice].
    Hollweg M; Krupinski M; Steinwachs A
    Med Monatsschr Pharm; 1997 Feb; 20(2):36-43. PubMed ID: 9132536
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparing 4 classification systems for drug-related problems: processes and functions.
    Björkman IK; Sanner MA; Bernsten CB
    Res Social Adm Pharm; 2008 Dec; 4(4):320-31. PubMed ID: 19064239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the pharmacist in reporting adverse drug reactions in the emergency department.
    Ratz Y; Shafir I; Berkovitch S; Sharristh M; Jacoby M; Kozer E; Golik A; Berkovitch M; Bar-Haim S
    J Clin Pharmacol; 2010 Oct; 50(10):1217-21. PubMed ID: 20418507
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Black box" warnings and drug surveillance.
    Menendez R
    J Allergy Clin Immunol; 2007 Mar; 119(3):759; author reply 759-60. PubMed ID: 17336622
    [No Abstract]   [Full Text] [Related]  

  • 27. How does use of a prescription monitoring program change medical practice?
    Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
    Pain Med; 2012 Oct; 13(10):1314-23. PubMed ID: 22845339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug utilization studies and drug monitoring in The Netherlands.
    Haaijer-Ruskamp FM; de Jong-van den Berg LT
    Ann Ist Super Sanita; 1991; 27(2):217-23. PubMed ID: 1755574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Institutional control of prescription blanks.
    Rapp RP; Sachatello CR
    Am J Hosp Pharm; 1975 Jan; 32(1):52-4. PubMed ID: 1168414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs and herbal preparations: how safe are they?
    Vesselago M
    Can Fam Physician; 1997 Jun; 43():1047. PubMed ID: 9189286
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Classification of drug-related problems].
    Ruths S; Viktil KK; Blix HS
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3073-6. PubMed ID: 18049498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1993.
    Pillans PI; Coulter DM
    N Z Med J; 1994 Nov; 107(990):490-3. PubMed ID: 7970369
    [No Abstract]   [Full Text] [Related]  

  • 34. Donald E. Francke medal lecture: International aspects of drug use and abuse.
    Francke DE
    Am J Hosp Pharm; 1974 Feb; 31(2):130-6. PubMed ID: 4815845
    [No Abstract]   [Full Text] [Related]  

  • 35. Inter-rater reliability of a classification system for hospital adverse drug event reports.
    Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical-pharmacological counseling in Odense, 1997-2003].
    Hedegaard U; Damkier P
    Ugeskr Laeger; 2004 Nov; 166(45):4030-2. PubMed ID: 15565960
    [No Abstract]   [Full Text] [Related]  

  • 37. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-related problems in medical wards with a computerized physician order entry system.
    Bedouch P; Allenet B; Grass A; Labarère J; Brudieu E; Bosson JL; Calop J
    J Clin Pharm Ther; 2009 Apr; 34(2):187-95. PubMed ID: 19250139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance.
    Weiss MC; Sutton J
    Sociol Health Illn; 2009 Apr; 31(3):406-21. PubMed ID: 19055585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polypharmacy. Reducing adverse events among the elderly in NJ. Part 1.
    Hare GT; Reinhard SC; Brick JH; Tepper C; Zanna MT
    N J Med; 1999 Dec; 96(12):35-8. PubMed ID: 10645137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.